Navigation Links
Air Methods Provides 4th Quarter Update
Date:1/27/2009

Key Measures In-Line with Internal Expectations

Higher Employee Healthcare Costs Impact Quarter by $0.06 per share

DENVER, Jan. 27 /PRNewswire-FirstCall/ -- Air Methods Corporation (Nasdaq: AIRM), the largest air medical transportation company in the world, provided an update on fourth quarter 2008 preliminary results.

Based on preliminary 2008 fourth quarter results, total community-based patient transports were 9,496. Patients transported for community bases in operation greater than one year (Same-Base Transports) decreased 831 transports or 8%, while weather cancellations for these same bases decreased by 394 transports compared with the prior-year quarter. Excluding the benefit of lower weather cancellations, Same-Base Transports decreased 12%, consistent with the third quarter 2008 decrease.

Preliminary net revenue per community-based transport increased slightly over the third quarter 2008 result of $7,090 per transport. Net revenue per community-based transport was $6,597 in the prior-year fourth quarter.

Preliminary maintenance expenditures per flight hour were slightly lower than the prior-year quarterly result of $572 per hour. The fourth quarter 2008 preliminary maintenance expense per hour moderated significantly from $673 per hour incurred in the third quarter of 2008.

The Company also announced that preliminary employee healthcare costs expensed by the company in the fourth quarter of 2008 were $1.2 million, or $0.06 per diluted share after taxes, higher than the prior-year fourth quarter. This represents a 39% increase per employee and was attributed to several large individual claims incurred during the quarter.

The Company noted that these preliminary results are subject to final year-end closing and independent audit proced
'/>"/>

SOURCE Air Methods Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
2. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
3. GPS-like technology helps pinpoint best methods for moving injured players
4. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
5. Manchester researchers announce new methods of beating breast cancer
6. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
7. Air Methods to Report Third Quarter Financial Results Before Market Open on Thursday, November 8, 2007
8. Air Methods Reports 3Q2007 Results and 4Q2007 Update
9. New Booklet Reveals 12 Proven Methods for Stopping MRSA from Infecting Your Feet and Your Familys Feet
10. Cold Spring Harbor Protocols features innovative methods for embryology research
11. Results promising for computational quantum chemical methods for drug development
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Negative Pressure Wound Devices Draw FDA Notice, Advice 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Cambridge Scientists Archive 500,000th Crystal Structure 2Surgical Care Affiliates Announces Investor Conference Call to Discuss 2009 Third Quarter Results 6114 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 2Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 3Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 4Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 5Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 1Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 2Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 3Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 4Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 5Keryx Biopharmaceuticals Inc Announces Third Quarter 2009 Financial Results 6104 6